Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

‘Miracle’ Cystic Fibrosis Drug Kept Out of Reach in Developing Countries

The New York Times – Business:

Vertex Pharmaceuticals is not making its drug, Trikafta, available in poorer countries, where thousands of diagnosed patients stand to benefit.

Stephanie Nolen
Author: Stephanie Nolen

This post first appeared in The New York Times – Business. Read the original article.

Written by

Stephanie Nolen

in

Brazil, Cystic Fibrosis, Drugs (Pharmaceuticals), Generic Brands and Products, India, Inventions and Patents, South Africa, Third World and Developing Countries, Turkey, Ukraine, Vertex Pharmaceuticals Inc
←Fifteen Percent Pledge Gala Calls on the Fashion Industry for Change
Young, Gifted And Black: Meet The Next Generation Of Black Hollywood→

More posts

  • Pope’s health should not be taken ‘for granted’, says top Vatican diplomat

  • Trump administration threatens to prosecute local California election workers

  • If You Can Get 5/5 On This Movie And TV Trivia Quiz, You Should Direct Your Own Film

  • Benjamin Satterley, wrestler known as Pac, died of bronchial asthma

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube